grant

Protease Activated Receptor 2 Antagonist In Inflammatory Disease [ 2010 - 2012 ]

Also known as: A New Drug That Binds Cell Surfaces And Blocks Inflammation

Funded by National Health and Medical Research Council
Managed by The University of Queensland
Managed by University of Queensland
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1000745]

Researchers: Prof David Fairlie (Principal investigator)

Brief description The immune response to infection involves a network of proteins that produce an inflammatory response. Sometimes this response is prolonged or uncontrolled and can lead to a large number of inflammatory and other diseases. We have discovered a class of drugs that can bind to a particular protein on the surface of human cells and control this inflammatory response. This property has the potential to treat a wide range of inflammatory and other diseases in humans.

Funding Amount $AUD 621,347.77

Funding Scheme NHMRC Development Grants

Notes Development Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Chemical Sciences | Medicinal and Biomolecular Chemistry | Molecular Medicine | arthritis | inflammation | inflammatory bowel disease (IBD) | inflammatory diseases | inflammatory mediators | protease inhibitors | protease-activated receptors |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA
ACN 633 798 857